Investor Series: Opportunities in RNA Therapeutics Market (mRNA Therapeutics and Vaccines, RNAi Therapeutics, and RNA Aptamers): Focus on Innovators Landscape, Analysis of Product Offerings and Company Health Indexing, Value Proposition Analysis, Company Competitiveness Analysis, Insights from Historical Funding and Investment Activity and Company Valuation, Financial Analysis and Business Risk Assessment of Key Public Ventures, Market Forecast and Opportunity Analysis, Analysis of Returns on Investment, Key Acquisition Targets